(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. IGF-1 stimulates protein metabolism via Akt (A) The ability of specific inhibitors of the p38 MAPK (SB=SB203580), p42 MAPK (PD=PD098059), the calcineurin (FK=FK506) and GSK-3
(LiCl) to prevent the increase in myosin content induced by IGF-1 was tested. Above each column the significance of the sample versus the control (upper) and versus the IGF-treated sample (lower) is given; NS, non significant; *P<0.05; **P<0.01. (B) The phosphorylation of Foxo1, p70S6K, GSK-3
and Akt was investigated by western blot analysis after treatment by IGF-1. (C) The effect of IGF-1 on the Foxo DNA binding activity of the cultures was investigated by EMSA. A competition with the unlabelled competitor oligo and a mutated probe were used to assess signal specificity. (D). The effect of IGF-1 on the expression of atrogin-1 was tested by northern blot analysis after a 3-hour treatment. Two mRNA forms of 2.4 kb and 6.5 kb were detected for atrogin-1, as described previously (Li et al., 2005).